Viracta Therapeutics Ceases Operations Following Nasdaq Delisting

Financial Collapse Triggers Immediate Liquidation

Viracta Therapeutics has officially terminated all business activities, marking a complete wind-down of the company. The firm’s website now confirms the full cessation of operations, concluding what was once a promising venture in the precision oncology sector.